Asger Aamund
Chairman of the Board
Chairman of the Board since inception of Bavarian Nordic in
1994.
Re-elected in 2012 for a one-year term. Not independent
Mr. Aamund is President & CEO of A.J. Aamund A/S, a holding
company focusing on the field of biotechnology. He was previously
CEO of Ferrosan, a Danish pharmaindustrial group.
Mr. Aamund is chairman of the board of Rehfeld Partners A/S and
member of the board of A.J. Aamund A/S.
Mr. Aamund is a Danish national, born in 1940.
The special competencies possessed by Mr Aamund that are
important for the performance of his duties in the Company are his
management experience from many years in the Danish and
international pharmaceutical industry. As a pioneer in Danish
biotech, Mr Aamund has had a key role in the establishment and
commercialisation of several companies and he is well experienced
in collaborations and partnering in the international
pharmaceutical industry.
